Save Product
Product Details
Product Specifications
Assay TypeSandwich-ELISAAnalyteGM-CSFFormat96T (8×12 strips)ReactivityHumanRegulatory StatusRUOSensitivity＜2.5 pg/mLStandard Curve Range2.5 pg/mL-80 pg/mLAssay Time3 hr 20 minSuitable Sample TypeFor the detection and quantitative determination of GM-CSF in cell culture supernatants.Sample volume100 μLProduct Overview
resDetect™ GM-CSF ELISA kit (Residue Testing)is based on the ELISA sandwich method and is used to detect and quantitatively determine Human GM-CSF residues in cell culture supernatants. The kit is suitable for use with GMP Human GM-CSF Protein (ACROBiosystems, cat# GMP-GMFH28) to ensure accurate assay results and is designed to provide a reliable solution for cell therapy product quality assessment during drug development and CMC quality control stages. It can also be used as a universal detection tool for the quantitative determination of Human GM-CSF.
Application
The kit is developed for the detection and quantitative determination of GM-CSF in cell culture supernates.
It is for research use only.
Storage
1. Store the unopened kit at 2-8°C upon receipt.
2. Locate the expiration date on the outer packaging and do not use reagents beyond their expiration date.
Materials Provided
IDComponentsSizeRES120-C01Pre-coated Anti-GM-CSF Antibody Microplate1 plate (8×12 strips)RES120-C02Human GM-CSF Standard20 μgRES120-C03Biotin-Anti-GM-CSF Antibody20 μgRES120-C04Streptavidin-HRP50 μLRES120-C0510×Washing Buffer50 mLRES120-C062×Dilution Buffer50 mLRES120-C07Substrate Solution12 mLRES120-C08Stop Solution7 mLACRO Quality Management System
Customers Also Viewed
Performance Data
Typical Data
Please refer to DS document for the assay protocol.
For each experiment, a standard curve should be generated for each microplate. The absolute OD values may vary depending on the laboratory, operator, or equipment. The example data provided below are for reference only.
Customer Reviews Writing Reviews
Recent Advances
Drug Development Progress- English Name：
Macrophage colony stimulating factor 2
- Category：
- Approved Drugs：
0 Details
- Drugs in Clinical Trials：
9 Details
- Highest Development Stage：
NDA/BLA
Contact Us
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
Drug Candidate Licensing
